Skip to main content
Journal cover image

Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity.

Publication ,  Journal Article
Moreb, EA; Hoover, B; Yaseen, A; Valyasevi, N; Roecker, Z; Menacho-Melgar, R; Lynch, MD
Published in: ACS synthetic biology
December 2017

Phage-derived "recombineering" methods are utilized for bacterial genome editing. Recombineering results in a heterogeneous population of modified and unmodified chromosomes, and therefore selection methods, such as CRISPR-Cas9, are required to select for edited clones. Cells can evade CRISPR-Cas-induced cell death through recA-mediated induction of the SOS response. The SOS response increases RecA dependent repair as well as mutation rates through induction of the umuDC error prone polymerase. As a result, CRISPR-Cas selection is more efficient in recA mutants. We report an approach to inhibiting the SOS response and RecA activity through the expression of a mutant dominant negative form of RecA, which incorporates into wild type RecA filaments and inhibits activity. Using a plasmid-based system in which Cas9 and recA mutants are coexpressed, we can achieve increased efficiency and consistency of CRISPR-Cas9-mediated selection and recombineering in E. coli, while reducing the induction of the SOS response. To date, this approach has been shown to be independent of recA genotype and host strain lineage. Using this system, we demonstrate increased CRISPR-Cas selection efficacy with over 10 000 guides covering the E. coli chromosome. The use of dominant negative RecA or homologues may be of broad use in bacterial CRISPR-Cas-based genome editing where the SOS pathways are present.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

ACS synthetic biology

DOI

EISSN

2161-5063

ISSN

2161-5063

Publication Date

December 2017

Volume

6

Issue

12

Start / End Page

2209 / 2218

Related Subject Headings

  • SOS Response, Genetics
  • Rec A Recombinases
  • Mutation
  • Genetic Engineering
  • Escherichia coli Proteins
  • DNA-Directed DNA Polymerase
  • CRISPR-Cas Systems
  • 3102 Bioinformatics and computational biology
  • 3101 Biochemistry and cell biology
  • 0903 Biomedical Engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moreb, E. A., Hoover, B., Yaseen, A., Valyasevi, N., Roecker, Z., Menacho-Melgar, R., & Lynch, M. D. (2017). Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity. ACS Synthetic Biology, 6(12), 2209–2218. https://doi.org/10.1021/acssynbio.7b00174
Moreb, Eirik Adim, Benjamin Hoover, Adam Yaseen, Nisakorn Valyasevi, Zoe Roecker, Romel Menacho-Melgar, and Michael D. Lynch. “Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity.ACS Synthetic Biology 6, no. 12 (December 2017): 2209–18. https://doi.org/10.1021/acssynbio.7b00174.
Moreb EA, Hoover B, Yaseen A, Valyasevi N, Roecker Z, Menacho-Melgar R, et al. Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity. ACS synthetic biology. 2017 Dec;6(12):2209–18.
Moreb, Eirik Adim, et al. “Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity.ACS Synthetic Biology, vol. 6, no. 12, Dec. 2017, pp. 2209–18. Epmc, doi:10.1021/acssynbio.7b00174.
Moreb EA, Hoover B, Yaseen A, Valyasevi N, Roecker Z, Menacho-Melgar R, Lynch MD. Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity. ACS synthetic biology. 2017 Dec;6(12):2209–2218.
Journal cover image

Published In

ACS synthetic biology

DOI

EISSN

2161-5063

ISSN

2161-5063

Publication Date

December 2017

Volume

6

Issue

12

Start / End Page

2209 / 2218

Related Subject Headings

  • SOS Response, Genetics
  • Rec A Recombinases
  • Mutation
  • Genetic Engineering
  • Escherichia coli Proteins
  • DNA-Directed DNA Polymerase
  • CRISPR-Cas Systems
  • 3102 Bioinformatics and computational biology
  • 3101 Biochemistry and cell biology
  • 0903 Biomedical Engineering